1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GSK PLC - ADR
51.05 0.83 (1.65%)
1.2M
XNYS Volume

XNYS 21 Sep, 2026 11:34 AM (EDT)

Watchlist

Portfolio

Alert

Acquisition
GSK to acquire Chimagen's experimental blood cancer drug in deal worth up to $750 million See details

GSK PLC (ADR) RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

GSK PLC (ADR) technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis